GP
FFTY icon

Geneva Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Geneva Partners’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,729
Closed -$399K – 86
2020
Q4 		$399K Buy
9,729
+809
+9% +$31.6K 0.21% 81
2020
Q3 		$333K Buy
+8,920
New +$329K 0.2% 71

Other funds holding FFTY

CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BFA
Beaumont Financial Advisors Needham, Massachusetts $1.46B AUM 21.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NEIRG
New England Investment & Retirement Group North Andover, Massachusetts $434M AUM 25.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geneva Partners's FFTY Position: Q1 2021 in Review

Geneva Partners sold out of CapForce IBD 50 ETF (FFTY) in Q1 2021, closing a stake of 9,729 shares — an estimated $399K sold.

Geneva Partners first reported a position in FFTY in Q3 2020 and held it in 2 quarters. The position peaked at $399K in Q4 2020. 68 funds tracked by Wall St. Rank hold FFTY as of Q1 2021.

  • Geneva Partners reported no remaining CapForce IBD 50 ETF position as of Q1 2021 after selling out during the quarter.
  • Geneva Partners sold 9,729 CapForce IBD 50 ETF shares in Q1 2021, an estimated $399K.
  • Geneva Partners first reported a position in CapForce IBD 50 ETF in Q3 2020 and held it in 2 quarters.
  • Geneva Partners's CapForce IBD 50 ETF position peaked at $399K in Q4 2020.
  • 68 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2021.

Based on Geneva Partners's 13F filing for Q1 2021, filed 5 May 2021.